• Search
  • Helpdesk
  • Sales contact

Emerging Biopharma & Biotech (EBP) – 5 key success factors for your clinical trials

Last updated : July 3, 2024

With so much at stake, consider partnering with an eCOA and DCT expert!

Kayentis offers a unified platform featuring trustworthy services to ensure the success of electronic Clinical Outcome Assessment (eCOA) and decentralized clinical trials (DCT):

  • 18+ years’ eCOA experience navigating diverse clinical trial challenges
  • A unified platform for decentralized clinical trials enhancing patient and site experience
  • Trusted partnership ensuring top-quality service delivery
  • Clinical and scientific experts empowering and supporting your teams
  • Therapeutic expertise addressing the unique needs of specific populations

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

5th Annual Clinical Trial Innovation Summit

JUNE 26, 2025 • Basel, CH
Clinical Trial Innovation Summit 2025 | June 26, 2025

The reckless value of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International